Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis

July 6, 2018

Mitsubishi Tanabe studies MT-7117 in phase II for erythropoietic protoporphyria

July 5, 2018

Conserved haplotype in SGLT1 is linked with lower risk of dietary hyperglycemia

July 5, 2018

Clinical trial authorization granted in U.K. for phase I study of FOR-6219

July 5, 2018

JCR initiates phase III trial of JR-401X for SHOX deficiency

July 4, 2018

Merck & Co. presents FFA1 receptor agonists

July 3, 2018

NovaTarg divulges new AMPK activators for diabetes

July 3, 2018

FDA grants fast track designation to CUTX-101 for treatment of classic Menkes disease

July 3, 2018

Cell therapies wake up and smell the coffee

July 3, 2018

JCR initiates phase II study of JR-141 as treatment of Hunter syndrome in Brazil

July 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...